ENDOMETRIOID OVARIAN CANCER
Clinical trials for ENDOMETRIOID OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID OVARIAN CANCER trials appear
Sign up with your email to follow new studies for ENDOMETRIOID OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis study is testing an experimental drug called TORL-1-23 for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to standard platinum-based chemotherapy. The drug specifically targets cancer cells that have a protein called CLD…
Matched conditions: ENDOMETRIOID OVARIAN CANCER
Phase: PHASE2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for women with resistant ovarian cancer
Disease control Recruiting nowThis early-stage study is testing whether combining two drugs, Cirtuvivint and Olaparib, is safe and tolerable for women with a specific type of ovarian cancer that has stopped responding to standard platinum-based chemotherapy. The trial will enroll about 50 women who have alrea…
Matched conditions: ENDOMETRIOID OVARIAN CANCER
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC
-
Virus therapy trial offers new hope for tough ovarian cancers
Disease control Recruiting nowThis study is testing if a modified virus called Olvi-Vec, given directly into the abdomen, can help chemotherapy work better for women with ovarian cancer that has stopped responding to standard platinum drugs. Participants will be randomly assigned to receive either the virus f…
Matched conditions: ENDOMETRIOID OVARIAN CANCER
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC